✦ LIBER ✦

Analysis of efficacy of DICE (dexamethasone, ifosfamide, cisplatin and etoposide) regimen on recurrent and refractory intermediate and high grade non-Hodgkin’s lymphoma

✍ Scribed by Yang, Lei ;Song, Zhucheng ;Xu, Xiaohong ;Wei, Jinzhi ;Tan, Qinghe ;Cong, Zhirong ;Peng, Chunlei

Book ID: 107513193
Publisher: Springer-Verlag
Year: 2009
Weight: 312 KB
Volume: 6
Category: Article
ISSN: 1672-7118
DOI: 10.1007/s11805-009-0059-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

810 Dexamethasone, etoposide, ifosfamide

810 Dexamethasone, etoposide, ifosfamide and cisplatin as second-line chemotherapy in intermediate or high grade non-Hodgkin's lymphoma

✍ N. Haim; M. Ben-Shahar; R. Epelbaum; E. Robinson 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Salvage therapy for non-Hodgkin's lympho

Salvage therapy for non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide, and cisplatin

✍ Nissim Haim; Edward Rosenblatt; Mira Wollner; Menachem Ben-Shahar; Ron Epelbaum; 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 236 KB

Clinical randomized comparative trial of

Clinical randomized comparative trial of DICE regimen and CHOP regimen in treating intermediate and high grade non-Hodgkin’s lymphoma

✍ Wenwu Wang; Xuenong OuYang; Zhangshu Cheng; Yonghai Peng; Fangwei Xie; Zongyang 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 169 KB

Treatment of relapsing and refractory no

Treatment of relapsing and refractory non-Hodgkin's lymphoma with a combination of dexamethasone, Ara-C, ifosfamide and cisplatin (DAIP)

✍ Haim, N.; Ben-Shahar, M.; Leviov, M.; Shklar, Z.; Omer, A.; Epelbarm, R. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 262 KB

Twin-track studies of ifosfamide and mit

Twin-track studies of ifosfamide and mitoxantrone (I-M) in recurrent high grade non-hodgkin's lymphoma and hodgkin's disease

✍ Dr J. A. Child; A. V. Simmons; D. L. Barnard; L. Parapia; M. Morgan; R. J. Grace 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Fifty-seven patients, initially diagnosed as having advanced high grade non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) refractory to first-line treatment or in relapse, were treated with ifosfamide 6 g/m2, infused over 48 h, followed by mitoxantrone 12 mg/m2. The regimen repeated at three-we

Alternating chemotherapy regimen (P-VABE

Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly

✍ Dr. F. Caracciolo; M. Petrini; E. Capochiani; F. Papineschi; G. Carulli; B. Gras 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB 👁 1 views

An intensive third generation regimen (P-VABEC) including adriamycin, etoposide, cyclophosphamide. vincristine, bleomycin and prednisolone was administered to 43 unselected elderly patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL). The median age was 67, 40 per cent were Ann Arb